Rezolute's rare disease drug fails main goal in late-stage trial
Rezolute(US:RZLT) Reuters·2025-12-11 20:05Rezolute said on Thursday its experimental drug for a rare condition that causes dangerously low blood sugar failed to meet the main goal in a late-stage study. ...